![J. Santiago Mejia](https://d2cax41o7ahm5l.cloudfront.net/cs/ocm/vaccines-immunization-2018-j-santiago-mejia--1758174269.jpg)
J. Santiago Mejia
Lead Scientist
Oxford Immunotec
USA
Biography
J. Santiago Mejia MD, PhD is a Research Scientist interested in the development of vaccines and diagnostic platforms to help prevent and control neglected diseases.He have experience with experimental models of several arthropod-borne diseases, including: Lyme borreliosis, leishmaniasis, LaCrosse viral encephalitis, filariasis, Chagas disease and malaria. While exploring strategies to control these diseases. He became interest in arthropod saliva as potential target of pan-arthropod vaccines. He also became interested in the powerful immuno-modulatory molecules present in arthropod saliva and how they could be used in the treatment and prevention of chronic non-communicable diseases. Finally, while looking for methods to induce protective anti-salivary immunity, participated in the development of an inducible lymphoid structure (BluePort) that can be used as vaccination portal and scaffold for tissue engineering.
Research Interest
Development of diagnostic tests for infectious, inflammatory, autoimmune and degenerative diseases.